Amsterdam institute for Immunology and Infectious diseases
AI&I news
Vulnerabilities in Immunocompromised Patients Highlighted by Re-emerging Measles Infections in the NetherlandsThe recent resurgence of measles in the Netherlands underscores the serious risks that vaccine-preventable diseases pose to immunocompromised individuals. Patients with impaired immune function, whether due to cancer, autoimmune disease, or other underlying conditions, remain highly susceptible to severe outcomes, even when standard prophylactic measures are followed. In such populations, the absence of antiviral immunity can render infections fatal, illustrating the critical importance of maintaining high vaccination coverage in the population.
Vidi Grants Awarded to Four Researchers from the Amsterdam Institute for Immunology and Infectious DiseasesThirteen talented scientists from Amsterdam UMC have been awarded a Vidi grant of up to €850,000 by the Dutch Research Council (NWO). This prestigious funding enables them to develop innovative research lines and establish their own research groups. We are proud to announce that four of the recipients are members of the Amsterdam Institute for Immunology and Infectious diseases (AI&I).
In the Spotlight January 2026: AI&I Prizes, Grants and Appointments Recently, several prestigious prizes and grants have been awarded to our AI&I members. Please congratulate: Prof. Dr. Esther Middelkoop and Prof. Dr. Ronald Vollenhoven. Learn more about these accomplished individuals and their projects in the article below!
